Filing Details

Accession Number:
0001140361-14-015676
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-04-03 17:55:49
Reporting Period:
2014-04-03
Filing Date:
2014-04-03
Accepted Time:
2014-04-03 17:55:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1056358 Mannatech Inc MTEX Medicinal Chemicals & Botanical Products (2833) 752508900
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1250072 A Larry Jobe 600 S Royal Ln #200
Coppell TX 75019
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2014-04-03 5,000 $18.12 30,000 No 4 P Direct
Common Stock, Par Value $0.0001 Per Share Acquisiton 2014-04-03 3,333 $5.19 33,333 No 4 M Direct
Common Stock, Par Value $0.0001 Per Share Acquisiton 2014-04-03 1,666 $5.72 34,999 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 M Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.0001 Per Share Right to Purchase Common Stock Disposition 2014-04-03 3,333 $0.00 5,000 $5.19
Common Stock, Par Value $0.0001 Per Share Right to Purchase Common Stock Disposition 2014-04-03 1,666 $0.00 5,000 $5.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,667 2022-05-29 No 4 M Direct
3,334 2023-02-21 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.76 to $18.20, inclusive. The reporting person undertakes to provide Mannatech, Incorporated, any security holder of Mannatech, Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote of this Form 4.
  2. One-third of the stock options vest on the date of grant (May 30, 2012), another one-third of the stock options vest on the first anniversary of the date of grant, and the remaining one-third of the stock options vest on the second anniversary of the date of grant.
  3. The options vest in three equal annual installments beginning February 21, 2014.